Secondary Postpartum Hemorrhage Following Vaginal Birth After Cesarean (VBAC) Successfully Managed With the JADA®

Preston A Phommathep1, Kaitlyn Santos1, Mackenzie Prosser1

  • 1Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Erie, USA.

Cureus
|March 20, 2026
PubMed

Postpartum hemorrhage (PPH) remains a significant cause of maternal morbidity, most commonly resulting from uterine atony. Management typically follows a stepwise approach using uterotonics and mechanical interventions when bleeding persists. We report the case of a 25-year-old G8P4043 (eight pregnancies, four carried to term, 0 preterm deliveries, four abortions, and three living children) woman at 38 weeks and three days' gestation who underwent a successful vaginal birth after cesarean complicated by a 45-second shoulder dystocia. Initial quantitative blood loss was 300 mL with a firm uterus. Approximately two hours postpartum, the patient developed acute uterine atony with severe pain and heavy vaginal bleeding, resulting in a cumulative blood loss of 2,055 mL. Emergency bedside ultrasound demonstrated a markedly thickened endometrial stripe with a large intrauterine clot burden and minimal vascularity. Despite uterine massage, high-dose oxytocin, misoprostol, and repeated bimanual clot evacuation, the uterus remained boggy. Second-line uterotonics were deferred due to severe hypertension and a history of significant asthma. A vacuum-induced uterine hemorrhage control device, JADA® System (Organon & Co., Jersey City, NJ, USA), was placed following manual evacuation of intrauterine clots, resulting in rapid improvement in uterine tone and bleeding. The device was removed approximately five hours later without complication. Hemoglobin declined from 11.6 g/dL to a nadir of 8.3 g/dL, and no blood transfusion or surgical intervention was required. This case highlights the importance of early recognition, bedside ultrasound assessment, and timely escalation to mechanical therapy in the management of severe primary PPH, particularly in high-risk patients with contraindications to standard second-line uterotonic agents.

Related Concept Videos

Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
571
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
364
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
551
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
395
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
106
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
515